Status:
RECRUITING
Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Universitaire Ziekenhuizen KU Leuven
Vrije Universiteit Brussel
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Breast cancer is the most frequently occurring cancer, assuming that it accounts for 29% of all new cancers in women (European Cancer Information System). The number of long-term survivors is increasi...
Eligibility Criteria
Inclusion
- Inclusion Criteria for breast cancer patients
- Patients scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy) for unilateral primary breast cancer or patients with oligometastatic breast cancer.
- Patients who receive adjuvant radiotherapy .
- Patients with a cognitive and language functioning enabling coherent Dutch communication between the examiner and the participant
- Patients who can comply with the protocol at baseline assessment and willing to provide written informed consent
- Inclusion criteria healthy volunteers
- Healthy women and men(quickDASH\<15) age- and gender-matched with a breast cancer patient from the main study
- Volunteers who can comply with the protocol at baseline assessment and willing to provide written informed consent
- Exclusion Criteria breast cancer patients
- BCS with widespread distance metastases, previous breast surgery, or planned bilateral surgery
- And/or with a diagnosis of a neurological or rheumatological condition, diabetes,
- And/or BCS who are not available the entire duration of the study
- Exclusion Criteria healthy volunteers
- History of breast cancer
- Patients with a diagnosis of neurological or rheumatological condition, diabetes
Exclusion
Key Trial Info
Start Date :
April 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05371847
Start Date
April 26 2022
End Date
February 1 2025
Last Update
May 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Leuven
Leuven, Belgium, 3000